Skip to content

AN2 Therapeutics, Inc.

ANTX Nasdaq SEC CIK 1880438

Follow AN2 Therapeutics Weekly email: filings, results, news

News

3 stories filed under AN2 Therapeutics, grouped into ongoing threads

Robin readnour

Thread · 2 stories

An2 therapeutics director Robin Readnour sells $97,322 in shares

Markets 16 d ago

An2 Therapeutics director Robin Readnour sells $212,701 in common stock

Markets 36 d ago 2 sources

More coverage

An2 therapeutics director buys $11,601 in common stock

Markets 22 d ago 2 sources

Profile

Headquarters: MENLO PARK, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 3 stories clustered from the RSS aggregator